Provided by Tiger Trade Technology Pte. Ltd.

Zai Lab Ltd

26.08
-0.7400-2.76%
Post-market: 26.080.00000.00%19:30 EDT
Volume:650.04K
Turnover:16.95M
Market Cap:2.93B
PE:-15.31
High:26.45
Open:26.45
Low:25.87
Close:26.82
52wk High:34.72
52wk Low:15.96
Shares:112.35M
Float Shares:97.11M
Volume Ratio:0.71
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7030
EPS(LYR):-1.6026
ROE:-26.91%
ROA:-14.75%
PB:4.83
PE(LYR):-16.27

Loading ...

Zai Lab presents new preclinical data on ZL-1503

TIPRANKS
·
Apr 20

Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting

MT Newswires Live
·
Apr 18

Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting

TIPRANKS
·
Apr 18

Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Apr 16

Zai Lab Shares Climb Over 4% on Partnership with Boehringer Ingelheim for Novel Dual DLL3-Targeting Combination Therapy

Stock News
·
Apr 16

Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Apr 15

Zai Lab Shares Climb Over 3% Following Global Clinical Partnership with Amgen for Zoci Candidate

Stock News
·
Apr 14

Zai Lab Ltd (1ZLB) Receives a Buy from CICC

TIPRANKS
·
Apr 11

Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)

Simply Wall St.
·
Apr 11

Zai Lab Grants Stock Options, Restricted Share Units, and Performance Share Units

Stock News
·
Apr 02

Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen

Deep News
·
Apr 02

Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment

Stock News
·
Apr 02

Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
Apr 01

Zai Lab Reports Fiscal Year Results with 15% Revenue Growth to $460 Million and Positive Pipeline Updates

Stock News
·
Mar 27

J.P. Morgan Sticks to Its Buy Rating for Zai Lab (ZLAB)

TIPRANKS
·
Mar 26

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 26

Shenwan Hongyuan Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Mar 19

Zai Lab price target lowered to $32 from $39 at JPMorgan

TIPRANKS
·
Mar 18

KeyBanc Remains a Buy on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Mar 15

Zai Lab Issues Equity Incentives Including Stock Options and Restricted Units

Stock News
·
Mar 13